Beijing Mygenostics Co.
Latest round
- Series C
Last raised
- Jan 2022
Total raised
- $16M
Investors
- 3
About Beijing Mygenostics Co.
, Ltd. is a gene technology company that focuses on the research and development of gene capture reagent products. In 2020, the company had gotten the qualification of COVID-19 testing by Beijing Health Care Commission., Ltd. The company has obtained 34 patented technologies, undertaken three science and technology projects of Beijing Science and Technology Commission, and co-authored more than 310 academic SCI papers. The company also has the patent for the design and manufacture of DNA capture probes. The company's products can be categorized into five different categories which are genetic testing, tumor detection, pathogen detection, health screening and COVID-19 testing. Products within include Nucleic Acid Extraction Kit, SARS-CoV-2 Real-time RT-PCR Diagnostic Panel, Automated liquid handler SIRO-3000, Biotin-16-UTP and etc. The company will focus on research and development of laboratory developed test(LDT) products, construction of gene big database and registration of clinical in vitro diagnostic(IVD) products and the construction of a marketing network system.
Who invested in Beijing Mygenostics Co.
3 investors across 2 rounds
See all investors in Beijing Mygenostics Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing Mygenostics Co.
Who invested in Beijing Mygenostics Co.?
Beijing Mygenostics Co. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Mygenostics Co. raised?
Beijing Mygenostics Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing Mygenostics Co. last raise money?
Beijing Mygenostics Co.'s most recent round on record is a Series C, in Jan 2022.
What does Beijing Mygenostics Co. do?
Beijing Mygenostics Co. is a biotechnology company.
Where is Beijing Mygenostics Co. headquartered?
Beijing Mygenostics Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Mygenostics Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Mygenostics Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Beijing Mygenostics Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.